Viridian Therapeutics Inc. Skyrocketed

Mon, Aug 15, 2022 at 07:00 PM
Viridian Therapeutics Inc. Skyrocketed

Viridian Therapeutics Inc. (VRDN:NASDAQ) rocketted at $22, a gain of 49.4%. On Mon, Aug 15, 2022, VRDN:NASDAQ hit a New 2-Week High of $22. The stock appeared on our News Catalysts scanner on Mon, Aug 15, 2022 at 04:33 PM in the 'PUBLIC OFFERING' category. From Mon, Aug 01, 2022, the stock recorded 70.00% Up Days and 63.64% Green Days

About Viridian Therapeutics Inc. (VRDN:NASDAQ)

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.